165 related articles for article (PubMed ID: 30359437)
1. E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding.
Allègre J; Cartier J; Glorian V; Droin N; Dumetier B; Kayaci C; Berthelet J; Gemble S; Vuillier C; Maillet L; Garrido C; Dubrez L
PLoS One; 2018; 13(10):e0206253. PubMed ID: 30359437
[TBL] [Abstract][Full Text] [Related]
2. DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.
Glorian V; Allègre J; Berthelet J; Dumetier B; Boutanquoi PM; Droin N; Kayaci C; Cartier J; Gemble S; Marcion G; Gonzalez D; Boidot R; Garrido C; Michaud O; Solary E; Dubrez L
Cell Death Dis; 2017 May; 8(5):e2816. PubMed ID: 28542143
[TBL] [Abstract][Full Text] [Related]
3. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
[TBL] [Abstract][Full Text] [Related]
4. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.
Feltham R; Bettjeman B; Budhidarmo R; Mace PD; Shirley S; Condon SM; Chunduru SK; McKinlay MA; Vaux DL; Silke J; Day CL
J Biol Chem; 2011 May; 286(19):17015-28. PubMed ID: 21393245
[TBL] [Abstract][Full Text] [Related]
5. Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription.
Cartier J; Berthelet J; Marivin A; Gemble S; Edmond V; Plenchette S; Lagrange B; Hammann A; Dupoux A; Delva L; Eymin B; Solary E; Dubrez L
J Biol Chem; 2011 Jul; 286(30):26406-17. PubMed ID: 21653699
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
[TBL] [Abstract][Full Text] [Related]
9. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.
Sun H; Lu J; Liu L; Yang CY; Wang S
ACS Chem Biol; 2014 Apr; 9(4):994-1002. PubMed ID: 24521431
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
12. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
[TBL] [Abstract][Full Text] [Related]
13. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M
Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235
[TBL] [Abstract][Full Text] [Related]
14. An unconventional IAP-binding motif revealed by target-assisted iterative screening (TAIS) of the BIR3-cIAP1 domain.
Kurakin A; Bredesen DE
J Mol Recognit; 2007; 20(1):39-50. PubMed ID: 17094177
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of C-terminal binding protein 2 by cellular inhibitor of apoptosis protein 1 via BIR domains without E3 ligase activity.
Seo TW; Lee YT; Lee JS; Yoo SJ
Biochem Biophys Res Commun; 2020 Sep; 530(2):440-447. PubMed ID: 32553630
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cIAP1 as a strategy for targeting c-MYC-driven oncogenic activity.
Li H; Fang Y; Niu C; Cao H; Mi T; Zhu H; Yuan J; Zhu J
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9317-E9324. PubMed ID: 30181285
[TBL] [Abstract][Full Text] [Related]
18. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
20. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
